Sexual dimorphism of neuroimmune interactions in temporomandibular joint disorders pain: contribution of a newly identified female-specific pain signaling axis IL23/IL17A/TRPV1

颞下颌关节疾病疼痛中神经免疫相互作用的性别二态性:新发现的女性特异性疼痛信号轴 IL23/IL17A/TRPV1 的贡献

基本信息

  • 批准号:
    10596384
  • 负责人:
  • 金额:
    $ 12.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Abstract Temporomandibular joint disorders (TMJD) are the most common form of chronic orofacial pain. TMJD affects approximately 10 million Americans and is up to 3 times more prevalent in women than in men. Moreover, clinical studies demonstrated that female TMJD patients exhibit greater pain than males. Unfortunately, precise mechanistic understanding of sexual dimorphism of TMJD pain remains largely unknown, hindering the attempts to develop female-selective pain therapies and improve pain management for female patients. We recently discovered that IL23/IL17A/TRPV1 signaling axis regulates somatosensory mechanical pain via neuro-immune interactions specifically in female naïve mice and in female mice with nerve injuries. At the immune cell level, interleukin 23 (IL23) stimulates the release of interleukin 17A (IL17A) from female, but not male, macrophages. Released IL17A evokes mechanical pain only in female mice via activation of TRPV1- expressing dorsal root ganglion (DRG) sensory neurons. These findings constitute a critical step forward in understanding of sex differences in pain. The overall goal of our parent R01 is to assess the extent to which TRPV1 and TRPA1 in trigeminal ganglion (TG) sensory neurons contribute to TMJD pain. In this exciting Administrative Supplement, we will determine whether this female-specific pain signaling IL23/IL17A/TRPV1 involving macrophage-sensory neuron crosstalk contributes to the sexual dimorphism of TMJD pain, which is mediated by trigeminal sensory system and has its own distinct etiologies. We believe this proposal will significantly complement our goal of the parent R01. More importantly, successfully addressing the proposed studies will greatly enhance our understanding why women are at a greater risk for developing TMJD pain and experience more severe TMJD pain than men, thereby advancing our quest for rationally-targeted new preventions and treatments for TMJD pain in women.
摘要 颞下颌关节紊乱病(TMJD)是最常见的慢性口面疼痛。TMJD影响 大约有1000万美国人,女性的患病率是男性的3倍。此外,委员会认为, 临床研究表明女性TMJD患者比男性表现出更大的疼痛。不幸的是,精确 对TMJD疼痛的性二态性的机械理解在很大程度上仍然未知,阻碍了对TMJD疼痛的研究。 尝试开发女性选择性疼痛疗法并改善女性患者的疼痛管理。我们 最近发现,IL 23/IL 17 A/TRPV 1信号轴通过调节躯体感觉机械性疼痛, 神经免疫相互作用,特别是在雌性幼稚小鼠和神经损伤的雌性小鼠中。在 在免疫细胞水平,白细胞介素23(IL 23)刺激雌性白细胞介素17 A(IL 17 A)的释放,但不刺激雌性白细胞介素17 A(IL 17 A)的释放。 雄性巨噬细胞释放的IL 17 A仅在雌性小鼠中通过激活TRPV 1引起机械性疼痛。 表达背根神经节(DRG)感觉神经元。这些研究结果是向前迈出的关键一步, 了解疼痛的性别差异。我们的父R 01的总体目标是评估 三叉神经节(TG)感觉神经元中的TRPV 1和TRPA 1参与TMJD疼痛。在这个激动人心 管理补充,我们将确定是否这种女性特异性疼痛信号IL 23/IL 17 A/TRPV 1 涉及巨噬细胞-感觉神经元的串扰有助于TMJD疼痛的性二态性, 它由三叉神经感觉系统介导,有其独特的病因。我们认为,这项建议将 这对我们的R 01目标有很大的补充作用。更重要的是,成功解决拟议的问题 研究将大大提高我们对为什么女性患TMJD疼痛的风险更大的理解, 经历比男性更严重的TMJD疼痛,从而推进我们对合理靶向新疗法的追求。 预防和治疗女性TMJD疼痛。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sensory Neuron-TRPV4 Modulates Temporomandibular Disorder Pain Via CGRP in Mice.
  • DOI:
    10.1016/j.jpain.2022.12.001
  • 发表时间:
    2022-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Suttle;Peng Wang;Fabiana C. Dias;Qiaojuan Zhang;Yuhui Luo;Lauren Simmons;A. Bortsov;I. Tchivileva;A. Nackley;Yong Chen
  • 通讯作者:
    A. Suttle;Peng Wang;Fabiana C. Dias;Qiaojuan Zhang;Yuhui Luo;Lauren Simmons;A. Bortsov;I. Tchivileva;A. Nackley;Yong Chen
Silencing of TRPV4-expressing sensory neurons attenuates temporomandibular disorders pain.
  • DOI:
    10.1177/17448069231185696
  • 发表时间:
    2023-01
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
  • 通讯作者:
Transient Receptor Potential (TRP) Ion Channels in Orofacial Pain.
  • DOI:
    10.1007/s12035-021-02284-2
  • 发表时间:
    2021-06
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Luo Y;Suttle A;Zhang Q;Wang P;Chen Y
  • 通讯作者:
    Chen Y
Involvement of Sensory Neurone-TRPV4 in Acute and Chronic Itch Behaviours.
  • DOI:
    10.2340/actadv.v102.1621
  • 发表时间:
    2022-02-22
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
  • 通讯作者:
Emerging Role of Transient Receptor Potential Vanilloid 4 (TRPV4) Ion Channel in Acute and Chronic Itch.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yong Chen其他文献

Yong Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yong Chen', 18)}}的其他基金

ClinEX - Clinical Evidence Extraction, Representation, and Appraisal
ClinEX - 临床证据提取、表示和评估
  • 批准号:
    10754029
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
Surrogate Augmented Deep Predictive Learning for Retinopathy of Prematurity
早产儿视网膜病变的替代增强深度预测学习
  • 批准号:
    10740289
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
开发磁共振指纹图谱 (MRF) 来评估乳腺癌新辅助化疗的反应
  • 批准号:
    10713097
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma
肾脏磁共振指纹图谱用于肾细胞癌评估的发展
  • 批准号:
    10522570
  • 财政年份:
    2022
  • 资助金额:
    $ 12.8万
  • 项目类别:
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma
肾脏磁共振指纹图谱用于肾细胞癌评估的发展
  • 批准号:
    10707150
  • 财政年份:
    2022
  • 资助金额:
    $ 12.8万
  • 项目类别:
PheBC: bias correction methods for EHR derived phenotype
PheBC:EHR 衍生表型的偏差校正方法
  • 批准号:
    10839649
  • 财政年份:
    2021
  • 资助金额:
    $ 12.8万
  • 项目类别:
PheBC: bias correction methods for EHR derived phenotype
PheBC:EHR 衍生表型的偏差校正方法
  • 批准号:
    10471166
  • 财政年份:
    2021
  • 资助金额:
    $ 12.8万
  • 项目类别:
CICADA: clinical informatics and computational approaches for drug-repositioning of AD/ADRD
CICADA:AD/ADRD 药物重新定位的临床信息学和计算方法
  • 批准号:
    10476677
  • 财政年份:
    2021
  • 资助金额:
    $ 12.8万
  • 项目类别:
TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting bias
TRiPOD:在 AD/ADRD 观察数据中实现可重复使用的表型 - 管理定义和纠正偏差
  • 批准号:
    10642888
  • 财政年份:
    2021
  • 资助金额:
    $ 12.8万
  • 项目类别:
TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting bias
TRiPOD:在 AD/ADRD 观察数据中实现可重复使用的表型 - 管理定义和纠正偏差
  • 批准号:
    10279554
  • 财政年份:
    2021
  • 资助金额:
    $ 12.8万
  • 项目类别:

相似海外基金

A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
Sedentary behavior, physical activity, and 24-hour behavior in pregnancy and offspring health: the Pregnancy 24/7 Offspring Study Administrative Supplement
久坐行为、体力活动和 24 小时行为对怀孕和后代健康的影响:怀孕 24/7 后代研究行政补充
  • 批准号:
    10893074
  • 财政年份:
    2023
  • 资助金额:
    $ 12.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了